HEMACORE
HemaCore was founded in 2010 as a biotech company focused on developing, manufacturing and implementing into clinical practice new in vitro diagnostic technology for hemostasis - thrombodynamics. Thrombodynamics assay – an innovative coagulation test for risk assessment of blood coagulation disorders – bleedings and thrombosis. Value proposition: they help clinicians succeed, providing clear and reliable estimation of patients coagulation state, thus giving an ability to prevent thrombotic or bleeding complications.
HEMACORE
Industry:
Biotechnology Health Care Medical Device
Founded:
2010-04-01
Address:
Moscow, Moscow City, Russian Federation
Country:
Russian Federation
Website Url:
http://www.hemacore.com
Total Employee:
51+
Status:
Active
Contact:
7 495 258 2538
Total Funding:
0
Technology used in webpage:
SPF
Similar Organizations
Devicare
Devicare is a biotech company developing medical treatments in Urology by combining innovative therapies with digital technologies
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
Investors List
RUSNANO
RUSNANO investment in Venture Round - HemaCore
Official Site Inspections
http://www.hemacore.com
- Host name: veronicafranko.ru
- IP address: 193.106.93.179
- Location: Moscow Russia
- Latitude: 55.7527
- Longitude: 37.6172
- Timezone: Europe/Moscow
- Postal: 129110
